PD‐L1 Expression is Mediated by microRNA Processing, Wnt/β‐Catenin Signaling, and Chemotherapy in Wilms Tumor

Documenti analoghi

• Impact of Hospital Volume on Survival for Pediatric Wilms Tumor
  di: Charbel Chidiac, et al.
  Pubblicazione: (2025)
• Anti‐Tumor Activity of Paclitaxel‐Containing Regimens in Recurrent/Refractory Wilms Tumor
  di: Alissa Groisser, et al.
  Pubblicazione: (2025)
• A Rare Intersection: Wilms Tumor in a Patient with PIGO Syndrome
  di: Şefika Akyol, et al.
  Pubblicazione: (2025)
• Correction to “Outcomes of Relapsed Favorable‐Histology Wilms Tumor in Non‐Clinical Trial Setting”
  Pubblicazione: (2025)
• Time Toxicity in Wilms Tumor: Quantifying the Burden of Healthcare Interaction in the First Year After Diagnosis
  di: Caleb Q. Ashbrook, et al.
  Pubblicazione: (2026)